Infertility Treatment Market

Report Overview

The global infertility treatment market was pegged at US$ 1.74 billion in 2020 and is expected to witness a CAGR of 7.8% during the forecast period.

Market Fundamentals

Infertility is defined as not being able to get pregnant (conceive) after one year (or longer) of unprotected sex. It is usually not the natural state of a healthy adult. Men and women both can have fertility problem. Fertility in women is known to decline steadily with age, whereas in men the infertility can generally related to poor lifestyle, smoking and alcohol consumption. In about 20% of infertile couples, both partners have fertility problems, and in about 15% of couples, no cause is found after all tests have been done. This is known as unexplained infertility. Fertility treatments often include medications that help with hormones and ovulation, sometimes combined with minor surgical procedures.

[6764543]

Market Dynamics

The global infertility treatment market is mainly driven by increasing prevalence of infertility coupled with changing lifestyle, growing number of fertility clinics globally, and technological advancements in the fertility treatment. Furthermore, increasing number of collaborations and partnerships among prominent players is also likely to play a pivotal role in contributing to the growth of the market globally. However, high cost of treatment is likely to restrain the market growth to a certain extent.

Market Ecosystem

The global infertility treatment market has been analyzed from five perspectives: Product Type, Procedure Type, Gender Type, End User, and Region.

Infertility Treatment Market by Product Type

[67545]

Based on product type, the infertility treatment market has been segmented into equipment, media & consumables, and accessories. The media & consumables segment dominated the market with the largest share in 2020. The growth of the segment can be attributed to the easy availability of culture media and other consumables containing various nutrients, vitamins, and growth factors.

Infertility Treatment Market by Procedure Type

Based on procedure type, the infertility treatment market has been segmented into assisted reproductive technology, artificial insemination, fertility surgery, and others. The assisted reproductive technology segment dominated the market with the largest share in 2020, owing to the greater success rate and favorable reimbursement policies for this procedure. The assisted reproductive technology segment is further categorized into in vitro fertilization, intracytoplasmic sperm injection, gamete intrafallopian transfer (GIFT), and others (zygote intrafallopian transfer (ZIFT), frozen embryo transfer (FET), etc.).

Infertility Treatment Market by Gender Type

Based on gender type, the infertility treatment market has been segmented into male, female and others. The male segment is anticipated to be the fastest growing gender type for infertility treatment during the forecast period. The growth of the segment can be attributed to rising prevalence of male sterility owing to poor lifestyle including smoking and alcohol consumption that can affect the sperm count and their quality.

Infertility Treatment Market by End User

Based on end user, the infertility treatment market has been segmented into hospitals & clinics, fertility centers, and others (cryobanks, research institutes, etc.). Fertility centers segment is anticipated to be the fastest growing end user segment during the forecast period. The growth of the segment can be attributed to the increasing number of fertility centers across the globe.

Infertility Treatment Market by Region

Based on region, the global infertility treatment market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (ROW). North America dominated the infertility treatment market, followed by Asia Pacific. The large share of North America in the global market can be attributed to developed healthcare infrastructure, presence of large number of fertility clinics, favorable reimbursement policies, and presence of prominent players.

Competitive Landscape

Some of the prominent players operating in the infertility treatment market includes:-

• Esco Micro Pte Ltd
• IVFtech ApS
• Fujifilm Irvine Scientific
• Rocket Medical plc
• Zeiss Microscopy
• Somatex Medical Technologies GmbH
• Cooper Surgical Fertility & Genomic Solutions
• Cook
• Vitrolife
• Genea Limited, among others

Strategic Developments

• In January 2021, Royal Philips, announced a multi-year partnership with Merck, to develop clinical-grade digital solutions for highly personalized fertility treatment. The partnership was aimed to better inform patients & clinicians about the choice and timing of fertility treatment to maximize the chances of conception
• In December 2020, Fresenius Helios acquired Eugin Group, from NMC Health. Eugin Group's network comprises 31 clinics and additional 34 sites across 9 countries on 3 continents. With about 1,300 employees, the company offers a wide spectrum of state-of-the-art services in the field of fertility treatments
• In January 2020, INVO Bioscience, Inc. and Medesole formed a joint venture to operate dedicated INVOcell clinics in India. INVOcell, also known as IVC, is the world's only in vivo Intravaginal Culture System, offering patients diagnosed with infertility an effective solution at low cost.

Frequently Asked Questions About This Report